MDxHealth S.A.
MDXHNASDAQHealthcare● Active
$0.55
$-0.02(-3.52%)
Market Cap$28045028
P/E Ratio—
52W High$5.33
52W Low$0.51
MDxHealth S.A. (MDXH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDXH · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.19
Est. -$0.14 · -31.4%
Revenue
$0.02B
Est. $0.03B · -22.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
MDXH reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.00
Rev. $1.80B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.00
Rev. Est.$1.80B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.19 | — | — | — | $0.03B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.14 | -$0.19 | -31.4% | $0.02B | $0.03B | -22.6% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.13 | -$0.19 | -46.1% | $0.03B | $0.03B | -2.7% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.11 | -$0.16 | -49.7% | $0.03B | $0.03B | -2.5% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.12 | -$0.16 | -33.3% | $0.05B | $0.03B | +103.2% |
| ▼ Q2 FY2025 | May 14, 2025 | -$0.13 | -$0.19 | -46.1% | $0.02B | $0.02B | +6.1% |
| ▼ Q2 FY2025 | May 14, 2025 | -$0.13 | -$0.19 | -46.1% | $0.02B | $0.02B | +1.7% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.27 | -$0.40 | -48.2% | $0.02B | $0.02B | +8.4% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.19
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.19
EPS Est.
-$0.14
EPS Surpr.
-31.4%
Revenue
$0.02B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.19
EPS Est.
-$0.13
EPS Surpr.
-46.1%
Revenue
$0.03B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.16
EPS Est.
-$0.11
EPS Surpr.
-49.7%
Revenue
$0.03B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.16
EPS Est.
-$0.12
EPS Surpr.
-33.3%
Revenue
$0.05B
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$0.19
EPS Est.
-$0.13
EPS Surpr.
-46.1%
Revenue
$0.02B
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$0.19
EPS Est.
-$0.13
EPS Surpr.
-46.1%
Revenue
$0.02B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.40
EPS Est.
-$0.27
EPS Surpr.
-48.2%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.13 | $-0.13 | $-0.12 | 1 |
| Q3 FY2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q2 FY2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q1 FY2027 | $-0.10 | $-0.10 | $-0.09 | 1 |
| Q4 FY2026 | $-0.25 | $-0.20 | $-0.15 | 5 |
| Q3 FY2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -31.4% | $1.87 | $1.95 | +4.28% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -46.1% | $3.53 | $3.55 | +0.57% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -49.7% | $4.45 | $4.12 | -7.42% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -33.3% | $4.45 | $4.12 | -7.42% |
| ▼ Q2 FY2025 | May 14, 2025 | -46.1% | $1.78 | $1.78 | +0.00% |
| ▼ Q2 FY2025 | May 14, 2025 | -46.1% | $1.78 | $1.78 | +0.00% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -48.2% | $2.07 | $2.08 | +0.48% |
| ▼ Q3 FY2024 | Aug 21, 2024 | -19.2% | $3.42 | $3.27 | -4.39% |
Q2 FY2026+4.28%
Report Date
May 13, 2026
EPS Beat/Miss
-31.4%
Price Before
$1.87
Price After
$1.95
Q1 FY2026+0.57%
Report Date
Feb 26, 2026
EPS Beat/Miss
-46.1%
Price Before
$3.53
Price After
$3.55
Q4 FY2025-7.42%
Report Date
Nov 12, 2025
EPS Beat/Miss
-49.7%
Price Before
$4.45
Price After
$4.12
Q4 FY2025-7.42%
Report Date
Nov 12, 2025
EPS Beat/Miss
-33.3%
Price Before
$4.45
Price After
$4.12
Q2 FY2025+0.00%
Report Date
May 14, 2025
EPS Beat/Miss
-46.1%
Price Before
$1.78
Price After
$1.78
Q2 FY2025+0.00%
Report Date
May 14, 2025
EPS Beat/Miss
-46.1%
Price Before
$1.78
Price After
$1.78
Q4 FY2024+0.48%
Report Date
Nov 6, 2024
EPS Beat/Miss
-48.2%
Price Before
$2.07
Price After
$2.08
Q3 FY2024-4.39%
Report Date
Aug 21, 2024
EPS Beat/Miss
-19.2%
Price Before
$3.42
Price After
$3.27
Avg Miss Reaction-1.74%
Beat Rate0 / 8 quarters
Largest Move-7.42% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDXH ends December
MDxHealth S.A. (MDXH) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.19 — missing the analyst consensus of $-0.14 by -31.4%. The next MDXH earnings date is expected around September 1, 2026.
Each quarter, investors track MDXH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDXH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDXH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDXH earnings · 5 questionsMDxHealth S.A.'s next earnings report is expected around September 1, 2026. MDXH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDXH historically reports after market close (AMC).
MDXH earnings datewhen is MDXH earningsMDXH next earnings datewhen does MDXH report earningsMDXH earnings calendar
▸ Source: FMP · MDxHealth S.A. SEC filings · US GAAP · MDxHealth S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026